Authors' Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
| Autor: | Gomes, Luis Eduardo Miani, da Silva, Francesca Aparecida Ramos, Pascoal, Lívia Bitencourt, Ricci, Renato Lazarin, Nogueira, Guilherme, Camargo, Michel Gardere, de Lourdes Setsuko Ayrizono, Maria, Fagundes, João José, Leal, Raquel Franco * |
|---|---|
| Zdroj: | In Clinics 2019 74 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|